Get the Stockscreener App
2.50
3.47%
-0.09
After Hours:
2.52
0.02
+0.80%
Codexis Inc stock is traded at $2.50, with a volume of 784.26K.
It is down -3.47% in the last 24 hours and up +2.88% over the past month.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$2.59
Open:
$2.63
24h Volume:
784.26K
Relative Volume:
0.89
Market Cap:
$225.67M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-2.2523
EPS:
-1.11
Net Cash Flow:
$-57.06M
1W Performance:
-7.06%
1M Performance:
+2.88%
6M Performance:
+6.38%
1Y Performance:
-20.63%
1-Day Range:
$2.455
$2.69
1-Week Range:
$2.455
$2.9299
52-Week Range:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.50 | 233.79M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Jun-03-24 | Resumed | Jefferies | Buy |
| May-30-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-29-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-07-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-07-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
Will Codexis Inc. price bounce be sustainableWeekly Stock Summary & High Accuracy Investment Entry Signals - newser.com
Codexis (CDXS) Reports Q4 Loss, Misses Revenue Estimates - MSN
Technical signs of recovery in Codexis Inc.2025 Top Gainers & Smart Investment Allocation Tips - newser.com
Detecting price anomalies in Codexis Inc. with AIEarnings Recap Summary & Short-Term Swing Trade Alerts - newser.com
Long term hold vs stop loss in Codexis Inc.Trade Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
CDXSCodexis Reports First Quarter 2025 Financial Results - ADVFN
What institutional flow reveals about Codexis Inc.Weekly Trade Recap & Community Verified Trade Signals - newser.com
Will Codexis Inc. bounce back from current support2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Will Codexis Inc. continue its uptrend2025 Risk Factors & High Win Rate Trade Alerts - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Codexis (NASDAQ:CDXS) - MarketBeat
Is Codexis Inc a good long term investmentHead and Shoulders Patterns & Demo Trading Rooms Open Daily - earlytimes.in
Codexis Inc Stock Analysis and ForecastPortfolio Risk Assessment & Build a Dividend-Powered Portfolio - earlytimes.in
Biocatalysis And Biocatalyst Market Rewriting Long Term Growth Story| Codexis, Amano Enzyme, Biocatalysts - openPR.com
Codexis (NASDAQ:CDXS) Stock Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Codexis Inc. stock retracement – recovery analysisJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
What does recent volatility data suggest for Codexis Inc.July 2025 Action & Daily Growth Stock Investment Tips - newser.com
Will Codexis Inc. stock recover after recent dropWeekly Trend Summary & Weekly Top Gainers Alerts - newser.com
News impact scoring models applied to Codexis Inc.Portfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
What analysts say about Codexis Inc stockRisk-Reward Ratio Analysis & Exceptional Profit Trading - earlytimes.in
Assenagon Asset Management S.A. Sells 372,591 Shares of Codexis, Inc. $CDXS - MarketBeat
Rhumbline Advisers Sells 7,421 Shares of Codexis, Inc. $CDXS - Defense World
Investors in Codexis (NASDAQ:CDXS) have unfortunately lost 79% over the last five years - Yahoo Finance
Codexis, Inc. $CDXS Shares Sold by Goldman Sachs Group Inc. - Defense World
Strs Ohio Buys New Position in Codexis, Inc. $CDXS - Defense World
Real time scanner hits for Codexis Inc. explainedGlobal Markets & Risk Controlled Daily Plans - newser.com
Applying sector rotation models to Codexis Inc.2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Is Codexis Inc. still worth holding after the dipQuarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Codexis Inc Stock (CDXS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Aug 04 '25 |
Buy |
2.83 |
780 |
2,211 |
12,545,000 |
| Opaleye Management Inc. | 10% Owner |
Jul 29 '25 |
Buy |
2.82 |
8,422 |
23,750 |
12,458,422 |
| Opaleye Management Inc. | 10% Owner |
Jul 30 '25 |
Buy |
2.79 |
1,578 |
4,411 |
12,460,000 |
| Opaleye Management Inc. | 10% Owner |
Jul 18 '25 |
Buy |
2.82 |
100,000 |
282,000 |
12,450,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 27 '25 |
Buy |
2.39 |
100,000 |
239,000 |
12,350,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 12 '25 |
Buy |
2.25 |
100,000 |
225,000 |
12,100,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 13 '25 |
Buy |
2.23 |
99,102 |
220,997 |
12,199,102 |
| Opaleye Management Inc. | 10% Owner |
Jun 16 '25 |
Buy |
2.24 |
50,898 |
114,012 |
12,250,000 |
| Opaleye Management Inc. | 10% Owner |
May 23 '25 |
Buy |
2.36 |
2,320,000 |
5,475,200 |
11,995,000 |
| Opaleye Management Inc. | 10% Owner |
May 28 '25 |
Buy |
2.36 |
5,000 |
11,800 |
12,000,000 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):